DGAT1 has been reported to be a therapeutic target in glioblastoma, and blocking DGAT1 in glioblastoma models has been found to prevent lipid droplet formation, initiate cell death in tumors, and notably decrease tumor growth [163]. The gene discussed is DGAT1; the disease is neoplasm.